3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Aila Rissanen, Lucyna Ostrowska et al.|The Lancet|2017

Cited by 843